The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic
Abstract
To assess the impact of COVID‐19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 versus 2020. Restrictions on social interaction due to the COVID‐19 pandemic were associated with a lower number of PEx events at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, portions of the open-label extension study that provided data for the current analysis occurred during the COVID-19 global pandemic, when social distancing and mask use likely led to a decline in pulmonary exacerbations [10] ; the impact on the estimated rate of change in ppFEV 1 in the present analysis is unknown.”
From EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS (2023) · cites this paper as [10]
In the citing paper
“This interim analysis overlapped with the SARS-CoV-2 pandemic, in which social distancing, restrictions on social interactions, and mask use might have partially impacted on some of the observed clinical outcome patterns, including PEx [21] .”
From Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study (2023) · cites this paper as [21]
Citations
Cites
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908639 · Cited by 2,198
Heijerman, H. G. M., McKone, E. F., Downey, D. G., Van Braeckel, E., Rowe, S. M., Tullis, E., Mall, M. A., Welter, J. J., Ramsey, B. W., McKee, C. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32597-8 · Cited by 1,414
Studdert, D. M., & Hall, M. A. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2007637 · Cited by 186 · cited 1×
“To The Editor, The COVID‐19 pandemic resulted in widespread restrictions on social interactions and lockdowns in many areas of the world.(1) The impact of these measures on cystic fibrosis (CF) pulmonary exacerbations (PEx) has not been described.”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Bower, J. K., Volkova, N., Ahluwalia, N., Sahota, G., Xuan, F., Chin, A., Weinstock, T. G., Ostrenga, J., & Elbert, A. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.03.002 · Cited by 140
Daines, C. L., Tullis, E., Costa, S., Linnemann, R. W., Mall, M. A., McKone, E. F., Polineni, D., Quon, B. S., Ringshausen, F. C., Rowe, S. M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.02029-2022 · Cited by 100
Lee, T., Sawicki, G. S., Altenburg, J., Millar, S. J., Geiger, J. M., Jennings, M. T., Lou, Y., McGarry, L. J., Van Brunt, K., & Linnemann, R. W. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.12.009 · Cited by 56
Metadata
- Authors
- Patel, S., Thompson, M. D., Slaven, J. E., Sanders, D. B., & Ren, C. L.
- Affiliations
- Indiana University School of Medicine Indianapolis Indiana USA
- Division of Pediatric Pulmonology, Allergy, and Sleep Medicine Riley Hospital for Children Indianapolis Indiana USA
- Department of Biostatistics Indiana University/Purdue University at Indianapolis Indiana USA
- Venue
- Pediatric Pulmonology
- Publisher
- Wiley
- Published
- 2021-01-12
- Volume
- 56
- Issue
- 5
- Pages
- 1271-1273
- ISSN
- 8755-6863
- 1099-0496
- Cited by
- 40
- References
- 3
- Language
- en
- Funders
- National Institutes of Health (T35HL110854)
- Cystic Fibrosis Foundation (SANDER18Y7)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
